Mirador Capital Partners LP Acquires New Stake in Cigna Group $CI

Mirador Capital Partners LP acquired a new stake in shares of Cigna Group (NYSE:CI) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 9,072 shares of the health services provider’s stock, valued at approximately $2,466,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. GK Wealth Management LLC raised its position in Cigna Group by 9.7% in the third quarter. GK Wealth Management LLC now owns 836 shares of the health services provider’s stock worth $227,000 after purchasing an additional 74 shares in the last quarter. Wedmont Private Capital boosted its stake in Cigna Group by 26.1% in the third quarter. Wedmont Private Capital now owns 11,623 shares of the health services provider’s stock worth $3,159,000 after purchasing an additional 2,406 shares in the last quarter. Journey Retirement Planning & Investment Management LLC lifted its position in Cigna Group by 45.0% during the 3rd quarter. Journey Retirement Planning & Investment Management LLC now owns 1,309 shares of the health services provider’s stock worth $356,000 after buying an additional 406 shares in the last quarter. Keystone Financial Planning Inc. bought a new stake in shares of Cigna Group during the third quarter valued at approximately $3,672,000. Finally, Acropolis Investment Management LLC bought a new position in Cigna Group in the 3rd quarter valued at $103,000. Institutional investors own 86.99% of the company’s stock.

Insider Activity at Cigna Group

In related news, insider Everett Neville sold 617 shares of the firm’s stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the transaction, the insider directly owned 5,053 shares of the company’s stock, valued at approximately $1,435,304.65. This trade represents a 10.88% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 19,436 shares of the company’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the sale, the insider directly owned 27,256 shares in the company, valued at $7,530,015.12. This trade represents a 41.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 22,730 shares of company stock worth $6,293,359 in the last ninety days. Insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. Raymond James Financial cut shares of Cigna Group from a “strong-buy” rating to an “outperform” rating and lowered their price target for the stock from $350.00 to $320.00 in a research report on Monday, August 3rd. Guggenheim raised their price objective on shares of Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a research note on Friday, July 31st. Wolfe Research reiterated an “outperform” rating and set a $315.00 target price on shares of Cigna Group in a research report on Tuesday, June 16th. Robert W. Baird set a $362.00 price target on Cigna Group in a research note on Friday, July 31st. Finally, Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, September 26th. Fifteen analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $338.24.

Cigna Group Stock Performance

CI opened at $282.24 on Friday. The company has a market capitalization of $74.58 billion, a price-to-earnings ratio of 11.68, a P/E/G ratio of 0.95 and a beta of 0.29. The business’s 50-day moving average price is $277.41 and its two-hundred day moving average price is $280.94. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. Cigna Group has a 1 year low of $239.51 and a 1 year high of $311.34.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company had revenue of $71.56 billion during the quarter, compared to analysts’ expectations of $70.14 billion. During the same period last year, the business earned $7.20 EPS. The business’s quarterly revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities analysts expect that Cigna Group will post 30.50 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th were issued a $1.56 dividend. The ex-dividend date was Tuesday, September 8th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is presently 25.82%.

Cigna Group Company Profile

The Cigna Group (NYSE: CI) is a global health company that provides health care and related services to individuals, employers, government organizations and health plans. Its operations are primarily organized through Cigna Healthcare and Evernorth Health Services, which together address health coverage, pharmacy services, care delivery and benefit management.

Cigna Healthcare offers medical, dental, behavioral health, disability and other benefits, with a focus on employer-sponsored and individual health plans in the United States as well as international health services.